BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 18801863)

  • 21. The endothelium and vascular inflammation in diabetes.
    Hartge MM; Unger T; Kintscher U
    Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.
    Groop PH; Forsblom C; Thomas MC
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):100-10. PubMed ID: 16929378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endothelial dysfunction and diabetes: possible role in kidney damage].
    Tesauro M; Leo R; Lauro R; Cardillo C
    G Ital Nefrol; 2009; 26 Suppl 46():62-70. PubMed ID: 19644821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity.
    Bakker W; Eringa EC; Sipkema P; van Hinsbergh VW
    Cell Tissue Res; 2009 Jan; 335(1):165-89. PubMed ID: 18941783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (Pre)diabetes, brain aging, and cognition.
    S Roriz-Filho J; Sá-Roriz TM; Rosset I; Camozzato AL; Santos AC; Chaves ML; Moriguti JC; Roriz-Cruz M
    Biochim Biophys Acta; 2009 May; 1792(5):432-43. PubMed ID: 19135149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diabetes mellitus and ischemic heart disease].
    Dresslerová I; Vojácek J
    Vnitr Lek; 2010 Apr; 56(4):301-6. PubMed ID: 20465100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The vascular effects of insulin].
    MAYALL RC; BRUM FA; AFIUNE M; KAWADA T
    Arq Bras Med; 1960; 50():463-8. PubMed ID: 14471671
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of endothelial dysfunction driven by adipocitokines in the development and progression of microvascular complications in patients with type 1 and type 2 diabetes.
    Blaslov K; Bulum T; Duvnjak L
    Med Hypotheses; 2015 Jun; 84(6):593-5. PubMed ID: 25792103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of the complications of diabetes.
    Vinik AI; Vinik E
    Am J Manag Care; 2003 Mar; 9(3 Suppl):S63-80; quiz S81-4. PubMed ID: 12653455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological mechanisms of stroke prevention by physical activity in type 2 diabetes.
    Agosti V; Graziano S; Artiaco L; Sorrentino G
    Acta Neurol Scand; 2009 Apr; 119(4):213-23. PubMed ID: 18700881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure.
    Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Stroke; 2007 Nov; 38(11):3016-22. PubMed ID: 17885259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection.
    Long AN; Dagogo-Jack S
    J Clin Hypertens (Greenwich); 2011 Apr; 13(4):244-51. PubMed ID: 21466619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Why should vascular patients have a dietary assessment?].
    Carsin M; Mahé G
    J Mal Vasc; 2010 Feb; 35(1):17-22. PubMed ID: 19959304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skin vascular alterations in diabetes mellitus.
    HANDELSMAN MB; MORRIONE TG; GHITMAN B
    Arch Intern Med; 1962 Jul; 110():70-7. PubMed ID: 13904305
    [No Abstract]   [Full Text] [Related]  

  • 36. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity impairs vascular relaxation in human subjects: hyperglycemia exaggerates adrenergic vasoconstriction arterial dysfunction in obesity and diabetes.
    Sivitz WI; Wayson SM; Bayless ML; Sinkey CA; Haynes WG
    J Diabetes Complications; 2007; 21(3):149-57. PubMed ID: 17493547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
    Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small artery remodeling in diabetes mellitus.
    Rizzoni D; Rosei EA
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):587-92. PubMed ID: 19481431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of diabetes mellitus and prevention of vascular disease].
    LENTI G
    Minerva Med; 1961 May; 52():1629-35. PubMed ID: 13760872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.